Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...

Nokian’s Surpass AS01 is a new all-season tire designed with low rolling resistance and comfort in mind. That’s due, in part, to there being more silica in the rubber compound of the AS01 than ...

We sampled the AS01 on two sporty-but-not-outright-fast sedans—a Mercedes-Benz C300 and an electric Polestar 2. We then moved to a time trial run with the Surpass AS01 fitted to a Toyota GR ...

An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.From March 2009 through January 2011, we e ...

The design of the Baseus AirGo AS01 isn’t new, though. We’ve seen something very similar with the Huawei FreeClip earbuds.But Huawei’s offering is on the expensive side, with the launch ...

For the first time, an effective new malaria vaccine — RTS,S/AS01 — has rolled out in Cameroon, Africa. RTS,S/AS01 has shown modest efficacy against symptomatic malaria in clinical trials.

The Nokian Surpass AS01 is an ultra-high-performance all-season tire with a 55,000-mile warranty, designed for stability and comfort. Tested on a track, it offers predictable handling and durability.

The Surpass AS01 isn't the first ultra-high-performance tire from Nokian—that would be the zLine A/S—but it's the first time Nokian has offered a tire in this segment in a few years.